Summary
Overview
Work History
Education
Certification
Trainings And Meetings
Associations Roles
Timeline
Generic
WULANING PUTRI SUNUWATI

WULANING PUTRI SUNUWATI

HEAD OF QUALITY, GOVERNMENT AFFAIRS AND BUSINESS DEVELOPMENT
Ciputat,South Tangerang

Summary

Experienced in Corporate Affairs with a demonstrated history of working in the medical device and pharmaceutical industry. I have strong and in-depth knowledge in Public Affairs, Market Access, Policy Shaping, Communication, and Government Affairs matters. Extensive exposure to governmental and various associations in different level, capabilities in handling public policy issue by engaging complex key stakeholders.


Innovative and analytical professional with knack for implementing effective quality management systems and continuous improvement strategies. Proficient in quality control processes and root cause analysis, with solid understanding of regulatory compliance and risk management. Committed to driving operational excellence and ensuring superior product quality.

Overview

20
20
years of professional experience
5
5
years of post-secondary education
2
2
Certifications

Work History

Head of Quality Regulatory, Government Affairs, and Business Development

PT. Siemens Healthineers Indonesia
02.2020 - Current
  • Government Affairs: working with stakeholders in Shaping Healthcare Systems, Promoting Innovation, Quality Healthcare, Regulatory Policy, Coverage & Reimbursement Policy responsible for leading the Indonesia GA function and developing the strategic plan in partnership with the country leadership work proactively to shape the external environment and influence decisions by policy makers, governments, regulatory bodies, law makers and business leaders to better position Siemens Healthineers to benefit customers, shareholders, and the business to sustain and accelerate growth
  • Quality: Ensures adherence to Quality management / assurance related processes and procedures, and oversees related operational and/or supportive activities Ensures procedures are in place for all business process, responsible for internal and external audits matters (GDPMDS, GMP) Management review process
  • Regulatory: Ensures availability and validity of product and business licenses required by the government, assurance the adherence with respective regulation, oversees related operational and/or supportive activities
  • EHS: Responsible for EHS scope, supporting process of system creation and the implementation across the organization

Head of Public Policy and Government Affairs

PT. Fresenius Medical Care Indonesia
11.2016 - 01.2020
  • Maintain a comprehensive and current understanding of Indonesian political landscape
  • Establish and build relationships with government and policy makers
  • Develop compelling arguments and execute advocacy initiatives to drive the company’s business success
  • Stakeholder engagement
  • Corporate Social Responsibility
  • Media handling
  • Public-private partnership MOU signing with Ministry of Health to accelerate the achievement of SDG’s in 2016
  • Successfully conduct the first joined CSR campaign with MOH, HCP association and patient group in World Kidney Day 2017
  • Successfully initiate Dialysis Forum Discussion with key stakeholders and submit the policy recommendation to the Minister of Health in 2018
  • Selected as one of talent pool in Asia Pacific region, being invited to present Indonesia’s Government Affairs best practice to the Asia Pacific Board of Director, Taiwan 2017

Public Policy Manager

PT. Roche Indonesia
11.2015 - 11.2016

Monitored legislative developments, ensuring timely adaptation of policies in response to changes.

  • Developed strong relationships with external partners for collaboration on key policy initiatives.
  • Coordinated communication strategies around key policies, ensuring consistent messaging throughout the organization.
  • Facilitated stakeholder meetings to gather input on emerging issues, fostering open dialogue and collaborative problem-solving approaches.
  • Advocated for organizational interests through active participation in industry conferences, workshops, and seminars related to pertinent policy topics.
  • Leveraged data-driven insights to inform evidence-based policymaking efforts across the organization.
  • Successfully develop ACTION Study report for Indonesia, i.e socio economic impact of cancer patients, work together with academician and regional colleagues in 2015
  • Successfully leverage the ACTION Study as policy recommendation to the Ministry of Health in 2016; the recommendation is being used for the National Cancer Plan developed by government

Senior Public Affairs and Communication Manager

PT. Novo Nordisk Indonesia
03.2015 - 11.2015
  • Established positive engagement with MOH by having public-private partnership MOU in 2012
  • Established new public-private partnership with local government in 4 provinces : DKI Jakarta, Aceh, Bali, Papua in 2013 – 2015
  • Successfully developed a Diabetes Blueprint for Change report for Indonesia in 2012, and launched by MOH with the endorsement from Danish Ambassador for Indonesia in 2013
  • Nominated as best three policy shaping initiatives by Global Communication Network in 2015; Novo Nordisk Indonesia Advocacy Initiatives from Zero to Hero
  • Successfully drive CSR initiatives; Novo Nordisk Indonesia has been rewarded as Indonesia Diabetes CSR Company of the Year by Frost and Sullivan for two years in a row, 2014 and 2015

Senior New Product Planning Officer

PT. Dexa Medica
07.2009 - 05.2011

Business Development Executive

PT Novell Pharmaceutical Laboratories
10.2004 - 06.2009

Education

Pharmacist Profession Program - Apothecary

University of Gadjah Mada
Yogyakarta, Indonesia
07.2003 - 06.2004

Bachelor Degree - Pharmacy

University of Gadjah Mada
Yogyakarta, Indonesia
07.1999 - 06.2003

Certification

ISO 13485:2018

Trainings And Meetings

  • Zurich, Switzerland, 11/01/11, Market Access and Health Economics training, Novo Nordisk A/S
  • Zurich, Switzerland, 04/01/12, Market Access workshop, Novo Nordisk A/S
  • Kuala Lumpur, Malaysia, 06/01/12, Issue Management Workshop, Novo Nordisk A/S
  • Jakarta, Indonesia, 02/01/13, One Day Seminar on The Need of Economic Evaluation and Health Technology Assessment for Universal Coverage, by Center for Health Economics and Policy Studies, Indonesia University
  • Jakarta, Indonesia, 04/01/13, Commercial Effectiveness training, Novo Nordisk A/S
  • Ho Chi Minh City, Vietnam, 04/01/13, BAOS SMMedMA Meeting, Novo Nordisk BAOS region
  • Bangkok, Thailand, 04/01/13, BAOS Management meeting, Novo Nordisk BAOS region
  • Jakarta, Indonesia, 05/01/13, Healthcare financing seminar, IPMG
  • Jakarta, Indonesia, 05/01/13, Pharmacoeconomy training, Center for Health Economics and Policy Studies, School of Public Health Universitas Indonesia
  • Yogyakarta, Indonesia, 06/01/13, Seminar Mengelola Rumah Sakit Menyesuaikan SJSN Kesehatan, Inhealth
  • Copenhagen, Denmark, 10/01/13, Market Access and Public Affairs Summit, Novo Nordisk A/S
  • Kuala Lumpur, Malaysia, 02/01/14, G-MAX Core Workshop, Novo Nordisk A/S
  • Jakarta, Indonesia, 03/01/14, Issue Management Workshop, Novo Nordisk A/S
  • Copenhagen, Denmark, 05/01/14, Advanced Diabetes Educator Course, Steno Diabetes Center
  • Denpasar, Indonesia, 07/01/14, BAOS Aspire Meeting, Novo Nordisk BAOS region
  • Copenhagen, Denmark, 11/01/14, Basic Global Public Affairs Academy, Novo Nordisk A/S
  • Jakarta, Indonesia, 05/01/15, Your Leadership Journey, Development Dimensions International (DDI)
  • Jakarta, Indonesia, 05/01/15, Building and Sustaining Trust, Development Dimensions International
  • Jakarta, Indonesia, 05/01/15, Communicating for Leadership Success, Development Dimensions International
  • Mainz, Germany, 05/01/15, Global Communication Summit, Novo Nordisk A/S
  • Jakarta, Indonesia, 12/01/15, Diskusi Publik: Transparansi dalam Konsep Pengadaan Obat di Era JKN, CHEPS
  • Copenhagen, Denmark, 03/01/16, International Experience Exchange Patient Organization, F. Hoffmann-La Roche
  • Singapore, 06/01/16, Value Recognition Workshop, F. Hoffmann-La Roche
  • Singapore, 08/01/16, APAC Access Meeting, F. Hoffmann-La Roche
  • Bangkok, Thailand, 01/01/17, Asia Pacific Management Kick – Off Meeting, Fresenius Medical Care
  • Singapore, 02/01/17, Renal Discovery Training, Fresenius Medical Care
  • Hongkong, 09/01/17, AP Government Affairs Community Meeting, Fresenius Medical Care
  • Taiwan, 10/01/17, AP Leadership Meeting, Fresenius Medical Care
  • Jakarta, Indonesia, 09/01/20, ISO 13485 training, Siemens Healthineers
  • Singapore, 09/01/23, Essentials Government Affairs Workshop, Vriens and Partners
  • Jakarta, Indonesia, 02/01/24, ISO 17025 training, Siemens Healthineers
  • Munich, Germany, 11/01/24, Global Quality Summit, Siemens Healthineers

Associations Roles

  • APACMed, Vice Chairperson APACMed Government Affairs and Market Access Indonesia Centre of Excellence, 2020-2023, 2023-2025, 2025-2027
  • GAKESLAB Indonesia, Head of Regulatory, Partnership, and Strategic Development Dept, 2021-2023, 2023-2027
  • EUROCHAM, Deputy of Pharmaceutical and Medical Device Working Group, 2019, now
  • IPMG, Public Affairs Working Group, 2012-2015

Timeline

Head of Quality Regulatory, Government Affairs, and Business Development

PT. Siemens Healthineers Indonesia
02.2020 - Current

Head of Public Policy and Government Affairs

PT. Fresenius Medical Care Indonesia
11.2016 - 01.2020

Public Policy Manager

PT. Roche Indonesia
11.2015 - 11.2016

Senior Public Affairs and Communication Manager

PT. Novo Nordisk Indonesia
03.2015 - 11.2015

Senior New Product Planning Officer

PT. Dexa Medica
07.2009 - 05.2011

Business Development Executive

PT Novell Pharmaceutical Laboratories
10.2004 - 06.2009

Pharmacist Profession Program - Apothecary

University of Gadjah Mada
07.2003 - 06.2004

Bachelor Degree - Pharmacy

University of Gadjah Mada
07.1999 - 06.2003
WULANING PUTRI SUNUWATIHEAD OF QUALITY, GOVERNMENT AFFAIRS AND BUSINESS DEVELOPMENT